A detailed history of Squarepoint Ops LLC transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 78,020 shares of BOLT stock, worth $58,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,020
Previous 79,772 2.2%
Holding current value
$58,515
Previous $89,000 22.47%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.01 - $1.4 $1,769 - $2,452
-1,752 Reduced 2.2%
78,020 $109,000
Q4 2023

Feb 14, 2024

BUY
$0.85 - $1.12 $13,395 - $17,650
15,759 Added 24.62%
79,772 $89,000
Q2 2023

Aug 14, 2023

BUY
$1.27 - $1.95 $81,296 - $124,825
64,013 New
64,013 $81,000
Q1 2022

May 16, 2022

SELL
$2.74 - $4.82 $38,738 - $68,145
-14,138 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.19 - $13.97 $59,238 - $197,507
14,138 New
14,138 $69,000

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $28.2M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.